Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AMBALALSA.BOthis companyAmbalal Sarabhai Enterprises Limited	₹35.63	10.46×	1.18×	0.92×	20.11×	-8.8%	23.1%	3.9%	8.8%	11.2%	3.5%	3.9%	0.36×	4.28×	1.91×	1.27×	0.0%	3	—	2	C+
BACPHAR.BOBacil Pharma Limited	₹16.82	43×	2.7×	0×	-270.7×	-93.7%	0.0%	0.0%	0.0%	6.3%	-1.0%	1.1%	0×	2.32×	0×	0.68×	0.0%	2	2.81	3	B-
BAFNAPH.NSBafna Pharmaceuticals Limited	₹472.80	23.31×	2.69×	1.72×	14.21×	-102.8%	13.4%	6.6%	7.4%	11.5%	7.2%	-5.1%	0.39×	1.71×	2.7×	1.57×	0.0%	5	—	1	C-
BDH.BOBDH Industries Limited	₹414.55	18.78×	2.64×	2.12×	10.9×	99.9%	18.4%	13.6%	11.3%	14.0%	11.4%	-0.1%	0.03×	-1.7×	213.65×	4×	1.3%	4	—	2	B-
FREDUN.BOFredun Pharmaceuticals Limited	₹1,518.80	25.02×	2.94×	1.29×	10.87×	-205.7%	26.6%	13.1%	5.2%	11.7%	10.9%	0.5%	0.87×	1.94×	2.12×	1.68×	0.0%	3	—	2	C
JENBURPH.BOJenburkt Pharmaceuticals Limited	₹959.75	12.14×	2.14×	2.5×	8.36×	76.8%	49.4%	24.1%	20.6%	17.6%	14.9%	3.9%	0.01×	-0.06×	87.95×	4.11×	1.9%	2	—	3	B
Peer median	—	23.31×	2.69×	1.72×	10.87×	-93.7%	18.4%	13.1%	7.4%	11.7%	10.9%	0.5%	0.03×	1.71×	2.7×	1.68×	0.0%	3	2.81	2	—